WHITEPAPER
Take the Colorectal Cancer Screening Pledge:
80% by 2018
Colon cancer is the second leading cause of cancer death in the U.S. among men and women combined
Did you know that colorectal cancer is the second leading cause of cancer death in the U.S.—both for men and women? That’s a sad statistic when you consider that this disease, often referred to as the silent killer, is one of the most preventable cancers.
Screening and early detection of colorectal cancer not only saves lives, but money and resources – for both the patient and the provider
Colorectal cancer is an expensive cancer to treat. The estimated costs for one year of treatment for a patient with late-stage colorectal cancer are as high as $310,000, with an estimated annual cost nationwide of $14 billion.
When adults are regularly screened, colorectal disease can be prevented through the detection and removal of precancerous polyps. Regular screening can also detect cancer at an early stage when treatment is most effective and the costs are significantly less.
Discover a Blueprint for Achieving 80% Compliance by 2018
The strategic plan developed by the National Colorectal Cancer Roundtable serves as a blueprint for achieving the national goal of screening 80 percent of the eligible population between the ages of 50 and 74 by 2018. The plan outlines four primary drivers for closing the screening gap and furthering the 80% by 2018 initiative: consumers, process, policy and systems.